Flonase (Fluticasone Propionate) Dosage and Usage
Standard Dosing Recommendations
For adults and adolescents ≥12 years, use 2 sprays per nostril once daily (200 mcg total dose), and for children ages 4-11 years, use 1 spray per nostril once daily (100 mcg total dose). 1
Age-Specific Dosing
Adults (≥12 years):
- Starting dose: 2 sprays (50 mcg each) per nostril once daily (200 mcg total) 1
- Alternative: 1 spray per nostril twice daily (100 mcg morning and evening) is equally effective 1
- Maintenance: After initial control, reduce to 1 spray per nostril once daily (100 mcg total) 1
- Maximum dose: Do not exceed 2 sprays per nostril daily (200 mcg) 1
Children (4-11 years):
- Starting dose: 1 spray per nostril once daily (100 mcg total) 1
- If inadequate response: May increase to 2 sprays per nostril once daily (200 mcg) 1
- Once controlled, decrease back to 1 spray per nostril daily 1
- Maximum dose: 2 sprays per nostril daily (200 mcg) 1
Children <4 years:
- Fluticasone propionate (Flonase) is not FDA-approved for children under 4 years 1
- For ages 2-3 years, consider fluticasone furoate (Veramyst) or mometasone furoate (Nasonex) as alternatives 2, 3
Proper Administration Technique
Critical steps to maximize efficacy and minimize side effects:
- Prime the bottle before first use by shaking and spraying until mist appears 2
- Shake the bottle before each use 2
- Have patient blow nose before administration 2
- Keep head upright during administration 2
- Use contralateral hand technique: Hold spray in opposite hand relative to the nostril being treated 2
- Direct spray away from nasal septum toward outer nasal wall (this reduces epistaxis risk by 4-fold) 2
- Breathe in gently during spraying 2
- Do not close the opposite nostril during administration 2
- If using nasal saline irrigations, perform them before the steroid spray 2
Treatment Duration and Timing
For optimal results, use at regular intervals rather than as-needed:
- Onset of action: 12 hours, with maximal efficacy reached in days to weeks 2
- For seasonal allergic rhinitis: Start before symptom onset and continue throughout allergen exposure period 2
- For perennial allergic rhinitis: Continue long-term with follow-up every 6 months if effective 2
- Once-daily morning dosing is as effective as twice-daily dosing for both seasonal and perennial allergic rhinitis 4, 5
Common Side Effects
Expected adverse effects include:
- Headache 3, 6
- Pharyngitis 3, 6
- Epistaxis (nosebleeds) 3, 6
- Nasal burning or irritation 3, 6
- Nausea or vomiting 3
- Cough 3
Important safety note: Proper contralateral spray technique significantly reduces epistaxis risk 2
Safety Considerations
Growth effects in children:
- No growth suppression occurs at recommended doses (200 mcg daily for one year showed equivalent growth to placebo) 7
- Studies with fluticasone propionate at recommended doses show no effect on growth compared to placebo 2
Hypothalamic-pituitary-adrenal (HPA) axis:
- No evidence of HPA axis suppression at recommended doses in children or adults 6, 5
- Morning plasma cortisol concentrations remain normal 6, 5
Long-term use:
- Safe for continuous daily use without risk of rhinitis medicamentosa (unlike topical decongestants which must be limited to 3 days) 2
- Periodically examine nasal septum during long-term use to detect mucosal erosions 2
Contraindications
Do not use in patients with:
When to Reassess Treatment
If inadequate response after 3 months of regular use:
- Consider adding intranasal antihistamine (azelastine) for combination therapy 2
- May consider short 5-7 day course of oral corticosteroids for severe symptoms 2
- Evaluate for alternative diagnoses or need for CT imaging 2
Clinical Efficacy Evidence
Fluticasone propionate is highly effective:
- More effective than oral antihistamines for all four major symptoms of allergic rhinitis 2
- More effective than leukotriene receptor antagonists 2
- Efficacy results from direct topical effects rather than systemic absorption 8
- Effective within 3 days of initiation with continued improvement throughout treatment 5